Intralesional Triamcinolone Acetonide in the Management of Acne Keloidalis Nuchae
DOI:
https://doi.org/10.70765/ebx1qj96Keywords:
Acne keloidalis nuchae; Intralesional triamcinolone; Keloid; Corticosteroid injection; DermatologyAbstract
Background: Acne keloidalis nuchae (AKN) is a chronic, scarring folliculitis that predominantly affects the occipital scalp and posterior neck, leading to significant cosmetic and psychological morbidity. Current treatment remains challenging, and recurrence is common.
Objective: This article reviews the efficacy and safety of intralesional triamcinolone acetonide (ILTA) in AKN and presents clinical insights into its application as a practical, cost-effective therapy.
Methods: A comprehensive review of the literature was undertaken using PubMed, Google Scholar, and regional databases. In addition, case experiences from patients treated with ILTA injections at a dermatology practice in Pakistan are highlighted.
Results: ILTA demonstrates significant efficacy in reducing inflammation, pruritus, and lesion size, with high patient satisfaction. Side effects such as atrophy and hypopigmentation are rare when administered at appropriate concentrations. Combination approaches (ILTA with antibiotics, laser, or surgery) further improve long-term outcomes.
Conclusion: ILTA is a cornerstone therapy for AKN, offering a safe and effective treatment option when delivered using proper technique and dosage.
Downloads
References
1. Khodaeiani E, et al. (2012. Intralesional triamcinolone in treatment of keloid and hypertrophic scars: a clinical trial. International Journal of Dermatology, 51(12, 1312–1317. doi:10.1111/j.1365-4632.2011.05330.x DOI: https://doi.org/10.1111/j.1365-4632.2011.05330.x
2. Ogunbiyi A. (2016. Acne keloidalis nuchae: prevalence, impact, and management challenges. Clinical, Cosmetic and Investigational Dermatology, 9, 483–489. doi:10.2147/CCID.S97035 DOI: https://doi.org/10.2147/CCID.S99225
3. Taylor SC. (2021. Acne keloidalis nuchae: advances in pathogenesis and management. American Journal of Clinical Dermatology, 22(3, 315–326. doi:10.1007/s40257-020-00589-2
4. Khodaeiani E, et al. (2012. Intralesional triamcinolone in treatment of keloid and hypertrophic scars: a clinical trial. International Journal of Dermatology, 51(12, 1312–1317. doi:10.1111/j.1365-4632.2011. 05330.x
5. Oluwasanmi JO, et al. (2019. Clinical evaluation of intralesional triamcinolone in the treatment of acne keloidalis nuchae. Journal of Cutaneous Medicine and Surgery, 23(6, 590–596. doi:10.1177/1203475419862857
6. Adebola O, et al. (2018. Acne keloidalis nuchae: clinical features and current management. Dermatologic Therapy, 31(5, e12659. doi:10.1111/dth.12659 DOI: https://doi.org/10.1111/dth.12659
7. Kelly AP. (2004. Pseudofolliculitis barbae and acne keloidalis nuchae. Dermatologic Therapy, 17(1, 31–37. doi:10.1111/j.1396-0296.2004.04003.x DOI: https://doi.org/10.1111/j.1396-0296.2004.04022.x
8. Adekoya-Cole TO, et al. (2015. Outcome of surgical excision and intralesional triamcinolone injection in acne keloidalis nuchae. Nigerian Journal of Clinical Practice, 18(5, 656–660. doi:10.4103/1119-3077.154214
9. Shapero J, et al. (2018. Intralesional corticosteroid therapy for dermatologic disease: a practical review. Journal of Cutaneous Medicine and Surgery, 22(5, 481–490. doi:10.1177/1203475418777053
10. Sperling LC, et al. (2000. Acne keloidalis nuchae: a clinicopathological study. Journal of the American Academy of Dermatology, 42(5, 709–716. doi:10.1067/mjd.2000.103985 DOI: https://doi.org/10.1067/mjd.2000.103985
11. Umar S, et al. (2019. Novel treatment strategies for acne keloidalis nuchae: review of literature and proposal of multimodal therapy. Journal of Drugs in Dermatology, 18(12, 1203–1210.
Downloads
Published
Data Availability Statement
No datasets were generated or analyzed during the current study. The article is based on a narrative review of the literature and case experiences from clinical practice.
Issue
Section
License
Copyright (c) 2025 Dr. Annas Sani (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
